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The virion RNA of Moloney murine leukemia virus (MuLV) has been trans-
lated in eukaryotic cell-free systems derived from mouse L- and human HeLa
cells. In both systems at least three polypeptides, approximately 60,000, 70,000,
and 180,000 in apparent molecular weight, were formed in response to the added
35S MuLV RNA. All three polypeptides were precipitable with antiserum to
detergent-disrupted MuLV. Fingerprint analysis of tryptic digests indicated
that all three contain amino acid sequences in common with each other and with
the major methionine-containing structural proteins of the virion.
The genome of the RNA tumor viruses is
made up of two to three apparently identical
RNA molecules, each of molecular weight 2.5 x
106 to 3 x 106, sufficient to encode polypeptide(s)
of total molecular weight 250,000 to 300,000.
The RNA carries the genetic information for
the major virion antigens, glycoprotein(s), and
reverse transcriptase, which amounts to about
200,000 in molecular weight. It is not yet clear,
however, if this is all that is coded (reviewed in
ref. 2).
As a direct approach to determining the in-
formation content of the genome, the virion
RNAs have been isolated from a number of
oncornaviruses and translated in a variety of
cell-free systems (9, 19, 23, 25, 28). One major
Rous sarcoma virus (RSV)-specific polypeptide
of molecular weight 70,000 to 80,000 was syn-
thesized in response to RSV RNA in a cell-free
system from Krebs II ascites tumor cells (28). In
addition, Naso et al. (19) have reported that the
translation of Rauscher murine leukemia virus
(RLV) RNA in extracts of starved RLV-infected
cells yielded at least two classes of polypeptides
of 50,000 to 70,000 and 140,000 to 185,000 in
molecular weight.
Here we report an investigation of the trans-
lation of Moloney murine leukemia virus
(MuLV) RNA in cell-free systems from mouse
and human cells. At least three major polypep-
tides of apparent molecular weight 60,000,
70,000, and 180,000 on electrophoresis in so-
dium dodecyl sulfate (SDS)-polyacrylamide
gels were formed in response to the added
MuLV RNA. An initial immunological charac-
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terization and tryptic fingerprint analysis of
these products is presented.
MATERIALS AND METHODS
Chemicals for use in the cell-free system and for
the isolation of cell fractions and viral RNA were as
described previously (8, 10-13). Spermidine (neu-
tralized with HCl) was from Sigma Chemical Co., St.
Louis, Mo.; [35S]methionine (100 to 450 Ci/mmol)
was from New England Nuclear Corp., Boston,
Mass.; encephalomyocarditis virus (EMC) was from
G. D. Searle and Co., Ltd., High Wycombe, Bucks,
England; TPCK trypsin was from Worthington Bio-
chemical Corp., Freehold, N.J.; and rabbit anti-goat
y globulin was from Microbiological Associates, Be-
thesda, Md. Goat antiserum to detergent (tween-
ether)-disrupted Moloney MuLV was obtained from
the National Cancer Institute, Bethesda, Md. (NCI
ID 1-S-0157).
Cells, virus, and viral RNA. Clone 1 Moloney
MuLV was derived and maintained as previously
(7). Clone 2 was obtained from clone 1 by end point
dilution of the virus on NIH-3T3 cells with immedi-
ate cloning of the cells after infection (M. Paskind,
D. Smotkin, and D. Baltimore, unpublished data).
For large-scale production of rapid-harvest virus,
productively infected cells were grown in roller
bottles in Dulbecco modified Eagle medium (DME)
with 10% calf serum. Virus was purified from me-
dium collected at 4-h intervals. This was clarified
by centifugation at 1,000 x g for 15 min at 4 C, and
the virus was pelleted at 27,000 x g for 2.5 h. The
virus was resuspended in TNE [50 mM tris(hydroxy-
methyl)aminomethane (Tris)-hydrochloride (pH
7.2), 100 mM NaCl, 1 mM ethylenediaminetetraa-
cetic acid] and centrifuged through a 25 to 45%
(wt/wt) sucrose gradient in TNE for 17 h at 82,000
x g at 4 C. The banded virus was pooled, diluted
threefold with TNE, pelleted by further centrifuga-
tion for 30 min at 160,000 x g, and resuspended in
TNE to a protein concentration of approximately
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20 mg/ml. SDS was added to a final concentration
of 2% prior to centrifugation for 2.5 h at 160,000 x
g at 22 C through a 15 to 30% (wt/wt) sucrose gradi-
ent in TNE, 1% SDS. The 70S virion RNA was
pooled and precipitated by the addition of two vol-
umes of ethanol. It was taken up in 2 mM sodium
acetate, 2 mM EDTA, 4 mM Tris-acetate (pH 7.3),
0.2% SDS, and denatured by heating for 2 min at
78 C (5). The heat-denatured virion RNA was cen-
trifuged for 5 h at 160,000 x g at 22 C through a
15 to 30% (wt/wt) sucrose gradient in TNE and 1%
SDS. The 35S RNA was pooled and precipitated
with ethanol. The precipitate was washed three
times with a mixture of two parts ethanol to one
part 100 mM sodium acetate (pH 6), dissolved in
water to a final concentration of 0.5 to 1 mg/ml, and
stored at -70 C.
The growth and purification ofEMC virus and the
preparation of EMC RNA have already been de-
scribed (11, 13).
['5Slmethionine-labeled MuLV. Clone 1 cells
were labeled at 37 C in DME with 10% dialyzed calf
serum, 0.75 mg of cold methionine per liter, and 10
to 15 ,uCi of [35S]methionine per liter. After 2 h the
medium was collected, and the cells were incubated
for a further 2 h in DME and 10% calf serum. The
two batches of medium were pooled, and the radio-
active virus was purified as above.
Preparation of cell extracts and the assay of
amino acid incorporation in the cell-free system.
The preparation and preincubation of postmitochon-
drial supernatant fractions from mouse L-cells were
as described (8). The post-mitochondrial superna-
tant fractions were dialyzed for 6 h at 4 C against
three changes of 10 mM N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid (HEPES) (pH 7.5), 90 mM
KCl, 1.5 mM magnesium acetate, and 7 mM 2-
mercaptoethanol (one hundred volumes in all) to
reduce the endogenous pool of amino acids. Assay
of amino acid incorporation was in 15-/il reaction
mixtures containing: 20 mM HEPES (pH 7.5); 75
mM (for MuLV RNA) or 110 mM (for EMC RNA)
KCl; mM (for MuLV RNA), or 2 mM (for EMC
RNA) magnesium acetate; 0.15 mM spermidine;
8 mM 2-mercaptoethanol; 1 mM ATP; 0.15 mM
GTP; 0.6 mM CTP; 10 mM creatine phosphate; 0.16
mg of creatine kinase per ml; 0.2 to 0.9 mCi of
[F3S]methionine per ml; unlabeled amino acids (each
100 ,M) minus methionine; 3 Al of L-cell extract(equivalent to approximately 50 ,tg of protein); and 1
A1 of reticulocyte ribosome wash-initiation factors
(16, 22). The amounts ofdifferent preparations ofthe
L-cell extract and reticulocyte factors used were ad-justed for optimum amino acid incorporation in each
case. The addition of the reticulocyte initiation fac-
tors had no detectable effect on the nature of the
polypeptide products synthesized but increased the
level of both endogenous and MuLV or EMC RNA-
stimulated amino acid incorporation two- to three-
fold. MuLV or EMC RNAs were added to final con-
centrations of 20 to 60 or 12 to 20 ,ug/ml, respec-
tively. Incubation was for 120 min at 30 C unless
otherwise stated. Preincubated and dialyzed postmi-
tochondrial supernatant fractions from HeLa and
Krebs II mouse ascites tumor cells were prepared
and assayed as for the L-cell extracts.
J. VIROL.
Immune precipitation. All sera were clarified by
centifugation for 10 min at 2,000 x g before use.
Samples (10 /Ll) of the cell-free system were diluted
with an equal volume of TNE, 1% NP40 and 1%
sodium deoxycholate and allowed to interact with 5
,4l of goat anti-MuLV or control serum for 10 min at
room temperature and then overnight at 4 C. The
mixture was diluted to 0.5 ml with TNE containing
1% NP40 and 40 Aul of rabbit anti-goat y globulin
serum and incubated as above. The precipitate was
pelleted at 2,000 x g for 10 min, washed three times
with TNE-0.5% NP40 and once with acetone, and
analyzed by electrophoresis on polyacrylamide gels.
Polyacrylamide gel electrophoresis. The polypep-
tides synthesized in the cell-free systems were pre-
cipitated with acetone, dissolved by boiling in 2%
SDS, 70 mM 2-mercaptoethanol, 62.5 mM Tris-hy-
drochloride (pH 6.8), 20% glycerol, and analyzed by
electrophoresis on 10% polyacrylamide slab gels con-
taining 0.1% SDS (14). Up to 25 samples, each equiv-
alent to 3 to 5 Al of cell-free system, could conven-
iently be run on a single gel. Alternatively, the
acetone-precipitated polypeptide products were
either redissolved in 8 M urea, 1% SDS, 170 mM 2-
mercaptoethanol, 5 mM Tris-glycine, or in 1% SDS,
100 mM 2-mercaptoethanol, 50 mM sodium phos-
phate (pH 7), boiled for 2 to 3 min, and analyzed on
cylindrical 7.5% polyacrylamide gels containing
0.1% SDS in the presence or absence of 5 M urea as
described by McDowell and Joklik (15) and Weber
and Osborn (29), respectively.
Analysis of tryptic peptides. Tryptic digestion of
35S-labeled purified MuLV and of the total polypep-
tide products synthesized in the cell-free system in
response to EMC RNA was carried out after precipi-
tation and performic acid oxidation as described pre-
viously (4), except that TPCK trypsin equivalent to
a total 20% by weight of the product to be digested
was used. Trypsin digestion of individual polypep-
tides was carried out on individual bands cut from
the stained dried gels after exposure for autoradiog-
raphy (17). The dried gel slices were swollen in a
slight excess by volume of TPCK trypsin (50 ,g/
ml) and 0.2 M NH4HCO3 (pH 8.5) and incubated
overnight at 37 C and for a further 4 h with a fresh
batch of trypsin. Recovery of radioactivity from the
gel slices was greater than or equal to 70%. The
peptide digests were lyophilized and resuspended in
10 to 20 ul of 0.3% NH40H, and 0.2- to 1.5-,ul sam-
ples were subjected to electrophoresis and chro-
matography on precoated thin-layer (0.1 mm) cellu-
lose plates (Brinkman Instruments Inc., Westbury,
N.Y.) as described previously (4), except that elec-
trophoresis at pH 3.5 was in pyridine-acetic acid-
water (1:10:100).
Autoradiography of the dried polyacrylamide gels
and thin-layer plates was with Kodak XOmat film
RP R54.
RESULTS
Electrophoretic analysis of polypeptide
products. To investigate whether MuLV RNA
can stimulate the synthesis of characteristic
polypeptides, 35S RNAs of clone 1 and clone 2
MuLV derived by heat denaturation of virion
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RNA were added to cell-free systems from
mouse L-cells. After electrophoretic separation
of the P15S]methionine-labeled products, three
major MuLV RNA-stimulated polypeptides
were evident on autoradiography of the dried
gels. These had apparent molecular weights of
60,000, 70,000, and 180,000 (60K, 70K, and
180K, arrowed Fig. lA). Occasionally the 60K
and 70K products migrated as poorly resolved
doublets. Essentially identical results were ob-
tained irrespective of whether the electropho-
retic analysis was carried out in slab gels after
denaturation in SDS and mercaptoethanol
(Fig. 1A) or in cylindrical gels in the presence
or absence of additional 8 M urea (15, 29; data
not shown). At the relatively low K+ ion con-
centration optimum for the translation of
MuLV RNA in the L-cell-free system (70 mM
compared with 110 mM for EMC RNA), there is
a relatively high level of endogenous amino
acid incorporation (slot 1, Fig. 1A) and only a
two- to threefold stimulation in response to the
added MuLV RNA. Under all of the conditions
tested here, however, the L-cell-free system
yielded more MuLV-specific polypeptide of
higher molecular weight than did the wheat
germ (21), Krebs ascites tumor cell, rabbit re-
ticulocyte (26), or the partially purified Krebs-
reticulocyte (1) cell-free systems (data not pre-
sented). The HeLa cell-free system yielded the
same products as did the L-cell-free system, but
in smaller amounts.
The virion RNA of MuLV already has at its
5'-end a 7-methylguanosine residue in 5'-5'
triphosphate linkage to the remainder of the
RNA (J. Rose, personal communication). In ac-
cord with this, the addition of S-adenosylme-
thionine or of S-adenosylhomocysteine was
without significant effect on amino acid incor-
poration or the spectrum of polypeptides formed
in response to MuLV RNA in these systems.
Kinetics of formation of the MuLV-specific
polypeptides in the L-cell-free system. To de-
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FIG. 1. Electrophoretic analysis of cell-free system products and the polypeptides ofpurified MuLV. (A) L-
cell-free system products in the presence and absence ofMuLVRNA orEMC RNA. Slot 1, minus MuLVRNA
(42,000 counts/min); slots 2 and 3, plus MuLV RNA clone 1 and clone 2 (95,000 and 70,000 counts/min,
respectively); slot 4, plus EMC RNA (130,000 counts/min); minus EMC RNA (not shown, 3,000 counts/min).
Each RNA was assayed under optimum conditions for that RNA (Materials and Methods). Material
equivalent to 3 kd ofeach cell-free system was analyzed by electrophoresis on a 10% acrylamide slab gel. (B)[35S]methionine-labeled MuLV was subjected to electrophoresis on a gradient (8 to 20% acrylamide) slab gel.
For both A and B an autoradiograph ofpart of the stained, dried gel is shown, and the numbers to the right
give the molecular weights in thousands of chick myosin and the major reovirion polypeptides A1, A2, p2,
and o-3 (24), which were included as nonradioactive markers. The 60K, 70K, and 180K MuLV RNA-
programmed products in (A) are indicated by the arrows to the left.
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three new polypeptides, samples of extracts in-
cubated for various times were submitted to
electrophoresis (Fig. 2). The 60K product was
first evident at 30 min and the 180K at 90 min,
as would be expected for newly initiated poly-
peptides of these sizes in this type of system.
The higher-molecular-weight EMC and polio-
virus RNA-directed polypeptide products, for
example, require comparable times for their
synthesis in vitro (Fig. 3 in reference 6; I. M.
Kerr, unpublished data). Translation in vivo is
considerably faster, but complete translation of
these latter RNAs takes 12 min even at 37 C
in the intact infected cell (3, 20).
Immunological characterization. The pre-
cipitability by a MuLV-specific antiserum of
the polypeptide products stimulated by MuLV
RNA was tested to determine if they were vi-
rus-specific. Using a HeLa cell-free system,
[35S]methionine-labeled products were made
with and without added MuLV RNA. They
were exposed to goat antiserum against deter-
gent-disrupted MuLV, and material reacting
with the serum was precipitated by rabbit anti-
goat immunoglobulin and analyzed by electro-
phoresis on polyacrylamide gels. Whereas a few
background polypeptides were carried down by
both immune and non-immune sera, all three
NO MLV RNA
30' 60 120' 1801
45 90' 180
of the MuLV RNA-stimulated polypeptides
were precipitated only by the anti-MuLV se-
rum and not by the corresponding control mate-
rial (Fig. 3). Essentially identical results were
obtained with L-cell extracts on similar immu-
nological analysis of the products formed in
response to the MuLV RNA (data not shown).
Fingerprint analysis of tryptic peptides. For
analysis of the tryptic digests of the MuLV-
specific products, the 60K, 70K, and 180K,
[P5S]methionine-labeled polypeptide bands
were eluted from stained dried polyacrylamide
gels by digestion with trypsin (17; Materials
and Methods). Autoradiographs of two-dimen-
sional thin-layer fingerprints of these digests
were compared with that obtained with a simi-
lar digest of the 130K to 140K polypeptide prod-
uct formed in response to EMC RNA in the L-
cell-free system and with those for digests ofthe
total virion polypeptides of purified MuLV, the
major MuLV group-specific antigen (P30) and
the major small [:15S]methionine-labeled poly-
peptide of MuLV (presumable P15, Fig. 1B;
Fig. 4, 5).
The products made in response to MuLV
RNA were clearly different from those pro-
grammed by EMC RNA (Fig. 4). The finger-
prints obtained from the 60K and 70K products,
-?-M ~ .,
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FIG. 2. Synthesis ofMuLV-specific polypeptides with time in the cell-free system. L-cell-free systems were
incubated in the presence and absence ofMuLV RNA. Samples (5 pid) were taken at the times (min) indicated
at the top of the figure and analyzed on a 10% acrylamide slab gel. [3,5]methionine incorporation at 180 min
was: minus MuLV RNA 30,000 and plus MuLV RNA 86,000 counts/min per 5 piu. The numbers to the left
give the molecular weights in thousands of marker polypeptides as in Fig. 1. The arrows to the right indicate











FIG. 3. Immune precipitation of the cell-free sys-
tem products synthesized in response to MuLV RNA.
HeLa cell extracts were incubated in the cell-free
system in the presence and absence of MuLV RNA
and subjected to immune precipitation. Plus MuLV
RNA: slot 1, control serum; slot 2, anti-MuLV se-
rum. No added RNA: slot 3, control serum; slot 4,
anti-MuLV serum. Electrophoresis was on a 10%
acrylamide slab gel. An autoradiograph ofpart ofthe
stained, dried gel is shown. The numbers to the right
and the arrows to the left are as described in the
legend to Fig. 1.
on the other hand, were indistinguishable and
bore no obvious relation to the background ma-
terial evident in digests of extracts to which no
RNA had been added (Fig. 4). All of the tryptic
peptides present in the digests of the 60K and
70K products (Fig. 4A, 4B, 5D) were also evi-
dent in the digest of whole virus (Fig. 5A),
many of which could be accounted for by those
present in the digests of the P30 and P15 (Fig.
5C and E). The fingerprint of the 180K product,
although closely related to that of whole virus
(Fig. 5A), was surprisingly similar to those for
the 60K and 70K products (Fig. 4A, 4B, and
5D). A few additional MuLV RNA-stimulated
peptides have been tentatively identified in the
basic region of the 180K map, and there could
be additional material in the congested band of
neutral peptides. The fact remains, however,
that for an increase of over 100,000 in apparent
molecular weight ofthe polypeptide from which
it was derived, the 180K fingerprint shows re-
markably little greater apparent complexity
than those for the 60 and 70K products.
The results in Fig. 4 and 5 were obtained
using electrophoresis at pH 6.5. Despite poorer
overall resolution, the general similarities and
differences observed with the different digests
were essentially confirmed by a further series
of fingerprints employing electrophoresis at pH
3.5 in the first dimension.
DISCUSSION
At least three polypeptides have been demon-
strated to be synthesized in response to MuLV
35S RNA added to cell-free systems from both
human and mouse cells. That these polypep-
tides are truly MuLV-specific has been shown
by their specific immunoprecipitability and by
fingerprint analysis of their tryptic peptides.
Whereas it is conceivable that the results ob-
tained with mouse L-cell extracts could reflect
an increased translation of endogenous mRNA
in response to the added RNA, it is extremely
improbable that this could be the case with the
human HeLa cell extracts. The results obtained
with the latter, therefore, clearly show that it is
the added MuLV RNA that is directing the
synthesis of the three MuLV-specific polypep-
tides in the cell-free systems. This, in turn,
confirms that the virion RNA is the messenger
strand for the RNA tumor viruses (2, 19, 38).
The near identity of the fingerprints of the
60K, 70K, and particularly the 180K products
with that for MuLV is striking (Fig. 4, 5). All of
the major PjS]methionine peptides present in
the 60K product are also present in the 70K,
and virtually all are present in the 180K. It
may be, therefore, that these are overlapping
polypeptides extending different distances from
the same initiation site on the RNA. The pep-
tide sequences common to all three products
(those in the 60K) are those of the major
structural virion core polypeptides (Fig. 1B, 5).
In this sense the 60K product may be analogous
to the precursor (Pre6O) to these latter poly-
peptides found in the infected cell (18, 27; M.
Paskind and David Baltimore, unpublished
data). Similarly, that at 180K could correspond
to the 140,000- to 185,000-molecular-weight pre-
cursor reported to be present in intact RLV-
infected cells and cell-free systems (18, 19).
There are several possible explanations for
the apparently small increase (if any) in the
complexity of the 180K map over those for the
60K and 70K products. Of these the simplest
are (i) aggregation; (ii) tandem repetition of the
information for the 60K sequences in at least
one of the virion RNAs; and (iii) the fact that
the sequences additional to the 60K sequence in
the 180K polypeptide are relatively poor in
methionine. The time of appearance of the
180K product after addition of MuLV RNA to
the cell-free system is in accord with its syn-
thesis as a unique polypeptide (Fig. 2). In addi-
tion we have no evidence for aggregation in
any of the three types of highly denaturing gel
system used for the electrophoretic analysis of
the products, and preliminary results suggest















FIG. 4. Fingerprint analysis of tryptic digests of polypeptide products formed in the cell-free system in
response to MuLV orEMC RNAs. (A) and (B) Polypeptides (60 and 70K) synthesized in the L-cell-free system





















FIG. 5. Fingerprint analysis of tryptic digests of [35S]methionine-labeled MuLV, of virion polypeptides,
and ofMuLV-specific products synthesized in the L-cell-free system. (A) Total MuLV virion polypeptides. (C)
and (E) MuLV-virion polypeptides P30 and P15, respectively. (B) and (D) Polypeptides (180K and 60K)
synthesized in response to the MuLVRNA in the L-cell-free system. (F) Endogenous polypeptide(s) of180,000
in molecular weight synthesized in the absence ofMuLV RNA under the same conditions as for B and D.
Loads in counts per minute were 12,000, 12,000, 7,000, 14,000, 2,200, and 6,000 for A, B, C, D, E, and F,
respectively. Autoradiography was for 21 days in all cases. The material used was that described in the legend
to Fig. 4.
system in response to EMC RNA. (D) endogenous polypeptide(s) of 60,000 molecular weight synthesized in
the absence ofMuLV RNA under the same cell-free system conditions as forA and B. After electrophoresis of
the cell-free system products as in Fig. 1, individual polypeptide bands were elated by digestion with trypsin.
Samples were applied to the bottom center (0) as shown of thin-layer cellulose plates. Electrophoresis was at
pH 6.5 with the anode to the left. PR indicates the position ofa phenol red marker. Chromatography was to-
wards the top of the sheet. For direct comparison, two samples were electrophoresed in parallel on the same
thin-layer plate which was cut in half for subsequent chromatography. Loads in counts per minute were
18,000,18,000, 40,000, and 6,000 for A, B, C, and D, respectively. Autoradiography ofA, B, and D was for
10 days. In this experiment and that shown in Fig. 5, 300-pd reaction mixtures were used in the cell-free sys-
tem assays. Total recoveries in the final tryptic digests were for plus MuLV RNA, 60K, 70K, and 180K,
440,000, 270,000, and 96,000 counts/min, respectively. In the absence of added RNA the corresponding
figures were 120,000, 80,000, and 40,000 counts/min.
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FIG. 5 B, D, F
the 180K, product can be detected in these
systems when smaller fragments of MuLV
RNA are used as messenger. Tandem repeats
remain an intriguing possibility, but they seem
a priori an unnecessary complication. Accord-
ingly, we would currently favor explanation
(iii), particularly as the presence of additional
non-methionine-containing MuLV-specific
amino acid sequences in the 180K product can
by no means be ruled out at this stage.
Which, if any, of these explanations is correct,
however, will have to await the results of a
more detailed analysis and the identification
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